INTS — INTENSITY THERAPEUTICS, INC.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2023-06-30.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-30 | Wesolowski John M Principal Accounting Officer | Grant or award | 3.7K | 3.48 | 12.9K |
| 2026-06-30 | Talamo Joseph Chief Financial Officer | Grant or award | 1.1K | 3.48 | 3.8K |
| 2026-03-26 | BENDER LEWIS H President and CEO | Grant or award | 37.7K | 6.11 | 230.6K |
| 2025-12-31 | Talamo Joseph Chief Financial Officer | Grant or award | 14.5K | 0.26 | 3.8K |
| 2025-12-31 | Wesolowski John M Principal Accounting Officer | Grant or award | 8.9K | 0.26 | 2.3K |
| 2025-06-30 | Wesolowski John M Principal Accounting Officer | Grant or award | 69.7K | 0.26 | 18.1K |
| 2025-06-30 | Talamo Joseph Chief Financial Officer | Grant or award | 14.2K | 0.26 | 3.7K |
| 2024-06-05 | Wesolowski John M Principal Accounting Officer | Option exercise | 1.0K | 4.00 | 4.0K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 153.0K | 26.0K |
| SAPIENT CAPITAL LLC | 152.9K | 26.0K |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 147.0K | 25.0K |
| Rothschild Wealth LLC | 137.0K | 23.3K |
| VANGUARD CAPITAL MANAGEMENT LLC | 99.0K | 16.8K |
| Mesirow Financial Investment Management, Inc. | 83.0K | 14.1K |
| VANGUARD FIDUCIARY TRUST CO | 53.6K | 9.1K |
| WELLS FARGO & COMPANY/MN | 1.2K | 200 |
| OSAIC HOLDINGS, INC. | 1.2K | 200 |
| UBS Group AG | 1.1K | 192 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Intensity Therapeutics (INTS) Q2 2026 Earnings Call Transcript · 2026-08-12
- Intensity Therapeutics, Inc. (INTS) filed form 8-K · 2026-08-11 · SEC EDGAR
- Intensity Therapeutics GAAP EPS of -$1.11 misses by $0.14 · 2026-08-11
- Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update · 2026-08-11
Ask the AI about INTS
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →